跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
INDIGO CARMINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
INDIGO CARMINE
Authorized
STANDARD
INDIGO CARMINE
Akorn Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
9c96c547f727392c
Company
Akorn Inc
Type
Standard
Approval Details
Approval Id
9c96c547f727392c
Drug Approval Canada Name
INDIGO CARMINE
Product Name
INDIGO CARMINE
Status
Cancelled Post Market
Status Date
2021-03-01
Original Market Date
1994-12-31
Din
02014815
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intramuscular , Intravenous
Schedule
Ethical
Ahfs
36:40.00
Atc Original
V04CH02 INDIGO CARMINE
Atc Name
v 04 ch 02
Aig Number
0107536001
Company Name
Akorn Inc
Company Address
300, 1925 West Field Ct, Lake Forest, Illinois, United States, 60045
Company Detail Path
/organization/akorn-inc-arlington-massachusetts-united-states
Company Information
Pharmaceutical Company Name
Akorn Inc
Country Name
United States
Province Name
Massachusetts
City Name
arlington,massachusetts,country_us
Address
13A Medford St
Active Ingredients
INDIGO CARMINE
0.8 %
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
9c96c547f727392c
Type
Standard
Back to Health Canada Approvals